OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
29
Results
Show all
Save search
Copy query
Show results for
Unknown
(29)
Publication Date
Release Date
2021
(7)
2022
(6)
2024
(5)
2025
(2)
2023
(2)
2017
(2)
2015
(2)
2026
(1)
2019
(1)
2016
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer.
Not available
S-EPMC6465407
|
biostudies-literature
Cite
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study.
Not available
S-EPMC7995808
|
biostudies-literature
Cite
Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study.
Not available
S-EPMC8206995
|
biostudies-literature
Cite
Prediction of breast cancer risk based on profiling with common genetic variants.
Not available
S-EPMC4754625
|
biostudies-literature
Cite
Evaluation of individual and ensemble probabilistic forecasts of COVID-19 mortality in the United States.
Not available
S-EPMC9169655
|
biostudies-literature
Cite
Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.
Not available
S-EPMC5731244
|
biostudies-literature
Cite
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
Not available
S-EPMC9792409
|
biostudies-literature
Cite
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Not available
S-EPMC4630206
|
biostudies-literature
Cite
Identification of six new susceptibility loci for invasive epithelial ovarian cancer.
Not available
S-EPMC4445140
|
biostudies-literature
Cite
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets